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Introduction: Impaired mobility and compromised manual dexterity leading to difficulties with the activities of
daily living (ADL) are an inherent part of the clinical picture in diabetes. Hand function in diabetes is influenced by
a variety of pathologies: the median nerve, the most important nerve of the hand, can suffer from metabolic
disturbances, ischemia and/or entrapment neuropathies. The resulting deterioration in functional capacity is likely to
have significant consequences for the ability to perform ADL, influencing adjustment to diabetes and affecting
quality of life. The aim of the present study was to examine the influence of hand function as measured by median
motor nerve conduction on quality of life, taking into account various aspects of functioning in patients with
diabetes, including activities of daily living, psychological status and acceptance of illness.
Patients and methods: Seventy one hospital patients with diabetes participated in the study. Electrophysiological
recordings of conductance in the median nerve were obtained for both hands and the relationship between hand
function and functional status (BI), depression and anxiety (HADS), adjustment to illness (AIS) and their effect on
quality of life (SF-36v2 and QLI) was studied.
Results: Damage to the median nerve of the left hand was associated with significant differences in functioning in
the physical, but not the mental component of the SF-36v2, p = 0.03 and in functional status (p = 0.006). QOL was
associated with depression, patient age, acceptance of illness, functional ability and to a small, but significant extent
with median nerve damage to the right hand on the measure of conduction velocities (R2 =0.726).
Conclusions: Nerve conductance studies demonstrated a small, but significant effect of hand function on quality of
life. Impairment of the median nerve in the left hand was associated with functional difficulties in the activities of
daily living and a diminished quality of life in the area of physical functioning. No dependencies of this kind were
found for the right hand, which may reflect the greater compensatory capacity of the right hand resulting from
improved efficiency due to practice.
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It is well established that diabetes is associated with vari-
ous complications, among the most common of which
are the peripheral neuropathies, often leading to func-
tional impairments affecting mobility and the activities
of daily living (ADL) [1,2]. The peripheral neuropathies
mostly affect the lower limbs which, as a result, have
been the focus of considerable research [3-7]. However,
they may eventually also involve the hands [8,9] and di-
minished hand strength has been associated with func-
tional disability in diabetes [10].
Hand function in diabetes is influenced by a variety of
pathologies, the most common presentations being car-
pal tunnel syndrome, trigger finger, Dupuytren’s contrac-
ture and limited joint mobility. The median nerve of the
hand, whose integrity is vital to normal hand function,
can suffer from metabolic disturbances, ischemia and/or
entrapment neuropathies. Nevertheless pathology in this
nerve often goes unrecognised: the signs of carpal tunnel
syndrome (CTS) are found in 20-30% of diabetic pa-
tients on electrophysiological examination [11], whereas
clinical signs are recognised in only 5.8% of patients
[12]. Moreover, the syndrome occurs three times more
frequently in diabetes than in the general population
[11]. Equally, diabetes can affect the median nerve as a
mononeuropathy or as part of a systemic polyneurop-
athy, both conditions being associated with widespread
nerve damage, not confined to the carpal region [13].
Median nerve dysfunction would be expected to cause
impaired hand function in the form of decreased muscle
strength, pain and impaired sensation and in conse-
quence to lead to an increased risk of burns and hand
ulceration [14].
It is reasonable to expect, that even mildly compromised
hand function in diabetes, which restricts the patient’s pre-
morbid dexterity and limits activities requiring fine manual
skills, might be reflected in feelings of deteriorated func-
tional capacity, resulting in lower subjective ratings of ill-
ness acceptance and mood and affecting perceptions of
quality of life. Very few studies have examined the relation-
ship between hand impairments, functional ability and
quality of life in patients with diabetes: Savas et al. [10]
obtained electrophysiological measurements for the sural,
median and peroneal nerves, but these parameters did not
correlate with their measure of functional disability for the
hands; and Padua et al. assessed nerve conductance in the
sural, peroneal, and ulnar nerve, but not in the median
nerve, in relation to quality of life [15]. However, most
studies have either addressed quality of life in diabetes
more generally or those that have examined hand function,
for example in relation to touch and temperature sensation
[2], restricted hand movement, Dupuytren’s contracture
[16], or the symptoms of carpal tunnel syndrome [17] have
not attempted to evaluate these in terms of quality of life.Diabetes-related morbidity [18] and the peripheral
neuropathies in particular, [19-21] are known to be asso-
ciated with poorer quality of life as reported by patients
with diabetes. Quality of life is regarded as an important
health outcome indicator in diabetes, alongside survival
time and the successful prevention and management of
complications, as it takes account of the effect of the ill-
ness on various aspects of the patient’s life as judged by
the patient him/herself and provides important informa-
tion in addition to the standard medical evaluation
[22,23]. As these evaluations are made in the context of
a long-term illness, the term ‘health related quality of
life’ (HRQoL) is used. Since there is no universally ac-
cepted ‘gold standard’ instrument that might provide a
holistic evaluation of patients with diabetes, an optimal
solution might be to combine both generic and diabetes-
specific instruments in the assessment of patients, and
this was the path taken in the present study. Further-
more, despite the multidimensionality of instruments
used to measure quality of life there is evidence that they
are measuring dimensions that are distinct from psycho-
pathology, and thus instruments to measure depression
and anxiety as well as illness acceptance were also in-
cluded, as it seemed likely that these might contribute to
quality of life in diabetes.
Thus, the aim of the present study was to investigate
the relationship between hand function as measured by
median nerve motor conduction and quality of life in
diabetes, taking into account a range of different vari-
ables, such as performance in the activities of daily liv-
ing, reported levels of illness acceptance, anxiety and
depression. In the first instance, the relationship between
demographic (e.g. age and gender) and clinical variables
(e.g. duration and severity of the illness) and impairment
in median nerve motor conduction was examined in
order to determine any effects of these variables on hand
function. Potential differences between right and left
hands were also examined.Methodology
Subjects
Seventy one patients admitted consecutively to the De-
partment of Endocrinology, Diabetology and Internal
Medicine of the Medical University Hospital in Białys-
tok, Poland participated in the study. Twenty one of the
patients had a diagnosis of type 1 and 50, type 2 diabetes
and all were right handed. Their mean age was 54.6 ±
14.3 years, (range 18–80 years); for the 37 women par-
ticipating in the study, it was 56.1 ± 14.4 years and for
the 34 men, 53.0 ± 14.3 years, with a mean illness dur-
ation of 18.2 years for women and 9.9 years for men.
Levels of HbA1c were used as an index of glycemic con-
trol, normal values of which should be ≤ 7% [24].
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Patients with both type 1 and type 2 diabetes were in-
cluded in the study; their selection was based on the fol-
lowing criteria: age below 80 years, satisfactory glycaemic
control with a blood glucose level of 90–140 mg% on the
day of examination and on the preceding day. Patients
with the symptoms of Dupuytren’s disease, CTS and
neurological conditions other than diabetic neuropathy
and those who were confined to bed or fitted with a pace-
maker were excluded from the study.
Ethical approval
Ethical permission for the study was obtained from the
Bioethical Committee of the Medical University of
Bialystok (R-I-002/115/2009). All patients were fully ap-
praised with the study protocols and gave their informed
consent.
Procedure
Motor nerve conduction studies of the median nerve
(distal motor latency-DML and conduction velocity -CV)
were performed according to standard techniques by
means of Keypoint equipment for all individuals [25]. All
the tests were carried out by a nurse trained in the proce-
dures, at an ambient room temperature of 22-25°C. A
bipolar electrode (9013 L0361) was used to stimulate the
median nerve and median motor onset latency was
recorded at the level of the elbow and wrist. Median
nerve neuropathy was diagnosed at distal latencies
greater than 3.8 ms and conduction velocities below
50 m/s in accordance with normal reference values
established in our laboratory; these values were taken
as the threshold for impairment on the electrophysio-
logical measures recorded [26].
Measures
Health related quality of life (HRQoL) was assessed
using the SF-36v2 [27] which provides summary scores
relating to the physical (PCS) and mental (MSC) compo-
nents of HRQoL, and is a generic measure in which
higher scores indicate better quality of life, and the
Quality of Life Index (QLI) for Diabetes Version III,
[28,29], which is a disease-specific measure of quality of
life in diabetes, with scores ranging from 0–30, higher
scores reflecting improved quality of life. Both instru-
ments were used in order to sample as wide a range of
domains of quality of life as possible, in keeping with the
criteria outlined in the introduction. Since hand dysfunc-
tion might be expected to be reflected in functional abil-
ities, a measure of performance on the activities of daily
living (ADL) was obtained with the aid of the Barthel
Index (BI): the scale is scored from 0–100, higher scores
being indicative of better functional performance
[29,30]. Measures of anxiety and depression wereobtained using the Hospital Anxiety and Depression
Scale (HADS) in which scores for each of the sub-scales
(anxiety or depression) range from 0–21, higher scores
indicating greater psychopathology [29], and the degree
of acceptance of illness was evaluated using the Accept-
ance of Illness Scale (AIS) [31], which consists of state-
ments describing the negative consequences of having
poor health status, scale scores range from 0–40, higher
scores being associated with better illness acceptance.
These two measures were included, as being potentially
likely to influence quality of life in diabetes. All of the
instruments have been validated for use in clinical
populations.
Analysis
Data analyses were carried out using the SPSS 17.0 stat-
istical package. Nonparametric tests were used because
of the non-normative or categorical nature of the data.
Comparisons between groups were made using the Odds
Ratio (OR), the Chi-square test for categorical data and
the Mann–Whitney test in the case of continuous vari-
ables. All tests were two tailed. The significance level ac-
cepted was p < 0.05. Spearman rank correlations and
step-wise linear multiple regression analyses were used
to establish relationships in the data. Predictor variables
for the regression model included the CV for both
hands, the demographic and clinical variables found to
discriminate between groups (gender and HbAIC) and
age of the patients, which although not significantly dif-
ferent between groups, showed some differences (see
Table 1). Other predictor variables of special interest in-
cluded: functional ability, as measured on the Barthel
(BI), the degree of illness acceptance (AIS) and the anx-
iety and depression measures obtained on the HADS.
The two dependent variables consisted of the generic
(SF36) and the specific (QLI) measures of quality of life.
Results
The clinical characteristics of the patients studied are
presented in Table 1; the sample is divided into those
with impaired versus unimpaired conduction in the me-
dian nerve in both hands. The mean values (±SD) for
the impaired versus unimpaired distal motor latencies
(DML) and conduction velocities (CV) are presented.
According to the measure of DML, impairment of the
median nerve in the right hand occurred in 49 patients
and in the left hand in 41 patients, whilst on the basis of
CV, impairment was found for 30 patients in the right
hand and 23 in the left. Impairment of function was
found to occur with similar frequencies in both right and
left hands (DML: OR = 1.63; p = 0.22 and CV: OR = 1.53;
p = 0.30). The differences in classification between DML
and CV may reflect the different sensitivity of the mea-
sures to damage in the median nerve; DML is likely to be
Table 1 Clinical characteristics of the diabetic patients examined according to impaired versus unimpaired DML
and CV of the median nerve for both hands
Distal motor latency (mean ± SD ms) (DML) Conduction velocities (mean ± SD m/s) (CV)
Left hand Right hand Left hand Right hand
Unimpaired Impaired Unimpaired Impaired Unimpaired Impaired Unimpaired Impaired
P
value
N = 30 N = 41 P
value
N = 22 N = 49 P
value
N = 48 N = 23 P
value























Age (years) 51.3 ± 16.8 56.9 ±
12.1
ns 52.3 ± 16.4 55.7 ±
13.3
ns 54.7 ± 15.4 54.4 ±
12.3







17(56.7%) 20(48.8%) ns 10(45.5%) 27(55.1%) ns 29(60.4%) 8(34.8%) 0.002 22(53.7%) 15(50%)
Men N(%) 13(43.3%) 21(51.2%) 12(54.5%) 22(44.9%) 19(39.6%) 15(65.2%) 19(46.3%) 15(50%)
Type of
diabetes
nsType I N(%) 12(40%) 9(21.9%) ns 7(31.8%) 14(28.6%) ns 14(29.2%) 7(30.4%) ns 12(29.3) 9(30%)
Type II N
(%)




13.6 ± 9.4 14.5 ±
11.1
0.03 12.5 ± 8.6 14.8 ±
11.1
ns 13.8 ± 11.1 14.7 ± 8.7 ns 12.2 ± 8.2 16.6 ±
12.3
ns
Hb A1C (%) 8.4 ± 2.9 9.3 ± 1.9 ns 9.2 ± 2.2 8.8 ± 1.9 ns 8.4 ± 1.7 9.8 ± 2.1 0.004 8.5 ± 1.8 9.4 ± 2.1 0.05
BMI (kg/m2) 30.5 ± 15.2 27.9 ± 4.9 ns 31.3 ± 17.2 28.0 ± 5.1 ns 29.3 ± 8.4 28.5 ± 6.6 ns 30.5 ± 13.1 27.1 ± 4.9 ns
Data are presented as means ± SD or%; group comparisons (impaired vs. unimpaired) were made using the odds ratio test for non-normally distributed
continuous variables and the chi-square test for categorical variables; BMI = body mass index, Hb A1C = c-fraction of glycosylated hemoglobin. P values are
expressed if they are <0.05.
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are the first to show neuropathic damage.
Within the sample studied, no significant differences
were found between impaired and unimpaired groups
on either of the median nerve measures (DML or CV)
for either hand with respect to the patient’s age, BMI
and type and duration of diabetes. The only exception to
this was in relation to the left hand, where longer illness
duration was associated with DML impairment (see
Table 1); a similar trend was also seen for the right hand
for DML, and for both hands with respect to CV, but
these comparisons did not reach statistical significance.
Statistically significant differences were found with re-
spect to CV, for men but not for women, and these dif-
ferences existed only for the left hand (OR = 0.04; p =
0.002). HbA1c values for the patient sample were high,
indicating poor overall glycemic control. Statistically sig-
nificant differences occurred in the left hand in relation
to the levels of HbA1c between the patients with im-
paired and non-impaired DML (OR = 1.51; p = 0.03) and
CV (OR = 1.85; p = 0.004) for the median nerve. For the
right hand, the difference between impaired and unim-
paired groups occurred only for CV (OR = 1.36; p =
0.05). Thus significant differences between impaired and
unimpaired groups were established mainly on measuresof CV and with respect to the left hand, in relation to
male patients and to levels of HbA1c.
Table 2 and Table 3 show the results of the functional
assessment in relation to hand dysfunctions as measured
by DML and CV. No differences between the groups were
found for ratings of acceptance of illness (AIS) and depres-
sion or anxiety scores (HADS) using the Mann–Whitney
test. However, significant group differences occurred with
respect to the measure of activities of daily living (BI)
for DML (p = 0.005) (see Table 2) and CV (p = 0.03)
(see Table 3) for the left hand, but not for the right.
Damage to the median nerve of the left hand (increased
DML) was associated with statistically significant differ-
ences in the functioning of the patient in the physical com-
ponent (PCS) of the SF36v2 (p = 0.01), but not in the
mental component (MCS). Left hand DML were also asso-
ciated with differences in the following subscales: physical
functioning (PF; p = 0.05) and physical role functioning (RP;
p = 0.03) (Table 2). The CV measure for the left hand dis-
criminated between impaired and unimpaired groups with
respect to the general health (GH) subscale (p = 0.03) and
bodily pain (BP) subscale (p = 0.03) of the SF36v2 (Table 3).
Significant differences were observed between CV impaired
and unimpaired groups in relation to QLI for the left hand
(p = 0.05) with respect to the health and functioning
Table 2 Functional assessment in the physical and psychological domains in relation to impaired versus unimpaired DML of the median nerve for both hands
Distal motor latency (mean ± SD ms) (DML)
Left hand Right hand
Unimpaired Impaired P value Unimpaired Impaired P value
N = 30 N = 41 N = 22 N = 49
Mean =3.4 ±0.2 ms Mean = 4.6 ±0.9 ms Mean = 3.4 ± 0.3 ms Mean = 4.9 ± 1.2 ms
AIS 31.7 ± 7.9 29.1 ± 8.6 ns 29.1 ± 8.7 30.6 ± 8.2 ns
CI 95% 28.8-34.7 26.3-31.8 25.2-32.9 28.3-33.1
HADS-D 4.8 ± 4.0 5.6 ± 5.1 ns 5.3 ± 5.2 5.3 ± 4.4 ns
CI 95% 3.34-6.33 4.0-7.2 2.9-7.6 4.0-6.6
HADS-A 5.6 ± 4.2 5.7 ± 5.3 ns 5.8 ± 4.8 5.6 ± 4.9 ns
CI 95% 4.07-7.19 4.1-7.4 3.7-7.9 4.2-7.1
BI 99.2 ± 2.9 93.9 ± 10.6 0.005 97.3 ± 6.8 95.6 ± 9.3 ns
CI 95% 98.1-100.3 90.6-97.3 94.2-100.3 92.9-98.3
SF-36v2
PF 49.1 ± 9.4 42.9 ± 13.1 0.05 46.9 ± 10.9 44.9 ± 12.5 ns
CI 95% 45.7-52.7 38.8-47.1 42.0-51.8 41.4-48.5
RP 44.3 ± 12.5 37.8 ± 13.1 0.03 41.1 ± 4.2 40.4 ± 12.8 ns
CI 95% 39.6 = 48.9 33.7-41.9 34.7-47.4 36.7-44.1
BP 52.5 ± 12.5 46.6 ± 14.5 ns 51.3 ± 12.2 48.2 ± 14.6 ns
CI 95% 47.9 = 57.2 42.1-51.2 45.9-56.7 43.9-52.3
GH 35.6 ± 12.4 35.3 ± 12.4 ns 37.2 ± 19.9 34.6 ± 11.6 ns
CI 95% 30.9-40.2 31.6-39.1 31.4-42.9 31.3-37.9
VT 46.3 ± 9.1 45.7 ± 12.4 ns 46.5 ± 9.8 45.7 ± 11.94 ns
CI 95% 42.8-51.6 41.8-49.6 42.2-50.9 42.3-49.1
SF 47.1 ± 11.8 40.5 ± 15.0 ns 42.7 ± 14.9 43.6 ± 13.8 ns
CI 95% 42.8-51.6 35.7-45.2 36.1-49.3 39.6-47.5
RE 43.1 ± 13.9 39.6 ± 13.9 ns 42.3 ± 13.9 40.5 ± 14.0 ns
CI 95% 37.8-48.3 35.2-43.9 36.1-48.5 36.5-44.5
MH 38.6 ± 13.9 39.8 ± 10.9 ns 38.8 ± 13.3 39.5 ± 11.1 ns
CI 95% 33.8-43.5 36.4-43.2 32.9-44.7 36.2-42.7
SF-36v2 48.7 ± 9.5 42.1 ± 11.5 0.01 46.5 ± 10.4 44.1 ± 11.4 ns
PCS CI 95% 45.0-52.2 38.5-45.7 41.9-51.1 40.8-47.4
SF-36v2 40.7 ± 12.8 40.6 ± 11.6 ns 40.5 ± 13.1 40.8 ± 11.7 ns






















Table 2 Functional assessment in the physical and psychological domains in relation to impaired versus unimpaired DML of the median nerve for both hands
(Continued)
QLI
HFSUB 20.2 ± 5.5 18.9 ± 4.7 ns 19.3 ± 5.9 19.5 ± 4.6 ns
CI 95% 18.2-22.3 17.5-20.4 16.7-22.0 18.2-20.8
SOCSUB 22.5 ± 4.1 20.3 ± 3.7 0.01 21.5 ± 4.2 21.1 ± 3.9 ns
CI 95% 20.9-24.0 19.1-21.5 19.6-23.3 19.9-22.3
PSPSUB 23.1 ± 4.9 21.6 ± 4.6 ns 22.7 ± 5.1 22.1 ± 4.6 ns
CI 95% 21.2-29.9 20.2-23.1 20.4-25.0 20.8-23.4
FAMSUB 24.8 ± 4.6 24.5 ± 4.1 ns 24.8 ± 5.0 24.5 ± 3.9 ns
CI 95% 23.1-26.6 23.2-25.7 22.6-27.0 23.4-25.7
QLI (Total) 21.9 ± 4.5 20.5 ± 3.8 ns 21.2 ± 4.8 21.1 ± 3.9 ns
CI 95% 20.2-23.6 19.3-21.7 19.1-23.3 19.9-22.2
Data are presented as means ± SD and CI-confidence interval; the Mann–Whitney U-test was used for group comparisons (impaired vs. unimpaired). P values are expressed if they are <0.05. (AIS) Acceptance of Illness
Scale, (HADS) Hospital Anxiety and Depression Scale, (BI) Barthel Index, SF-36v2 = (PF) physical functioning, (SF) social functioning, (RP) physical role functioning, (RE) emotional role functioning, (BP) bodily pain, (GH)
general health, (VT) vitality, (MH) mental health, (PCS) physical component summary, (MSC) mental component summary, QLI-Quality of Life Index for Diabetes Version III = HFSUB- health and functioning subscale,






















Table 3 Functional assessment in the physical and psychological domains in relation to impaired versus unimpaired CV of the median nerve for both hands
Conduction velocities (mean =m/s)(CV)







N = 48 N = 23 N = 41 N = 30
Mean = 54.5 ± 3.5 m/s Mean = 46.1 ± 2.8 m/s Mean = 54.1 ± 3.4 m/s Mean = 45.8 ± 2.7 m/s
AIS 30.8 ± 7.9 28.8 ± 9.2 ns 30.6 ± 7.8 29.6 ± 9.1 ns
CI 95% 28.5-33.1 24.9-32.9 28.2-33.1 26.1-32.9
HADS-D 4.8 ± 4.7 6.2 ± 4.2 ns 4.6 ± 4.4 6.1 ± 4.9 ns
CI 95% 3.4-6.2 4.4-8.1 3.3-6.0 4.3-8.0
HADS-A 5.4 ± 5.1 6.2 ± 4.2 ns 5.6 ± 4.7 5.7 ± 5.1 ns
CI 95% 3.9-6.9 4.3-8.0 4.1-7.1 3.9-7.6
BI 97.0 ± 8.5 94.3 ± 8.8 0.03 96.5 ± 9.0 95.6 ± 8.2 ns
CI 95% 94.5-99.5 90.5-98.1 93.6-99.3 92.6-98.7
SF-36v2
PF 45.8 ± 11.8 45.0 ± 12.5 ns 46.6 ± 10.9 44.1 ± 13.4 ns
CI 95% 42.4-49.3 39.6-50.4 43.2-50.1 39.1-49.1
RP 41.6 ± 12.6 38.3 ± 14.3 ns 41.3 ± 13.2 39.6 ± 12.2 ns
CI 95% 37.9-45.3 32.2-44.6 37.1-45.5 34.6-44.5
BP 51.9 ± 12.8 43.2 ± 14.6 0.03 49.6 ± 13.8 48.4 ± 14.1 ns
CI 95% 48.3-55.7 36.9-49.5 45.3-54.0 43.1-53.7
GH 37.6 ± 12.3 30.9 ± 10.1 0.03 36.5 ± 11.7 33.8 ± 12.4 ns
CI 95% 33.9-41.1 26.5-35.3 32.9-40.2 29.2-38.5
VT 45.9 ± 11.1 46.1 ± 11.7 ns 47.1 ± 9.9 44.5 ± 12.8 ns
CI 95% 42.7-49.1 41.1-51.2 43.9-50.2 39.7-49.3
SF 44.8 ± 13.5 39.9 ± 14.6 ns 44.9 ± 12.8 41.0 ± 15.4 ns
CI 95% 40.9-48.8 33.6-46.4 40.9-49.1 35.2-46.8
RE 42.8 ± 12.8 37.3 ± 15.6 ns 41.0 ± 14.4 41.1 ± 13.5 ns
CI 95% 39.1-46.6 30.6-44.0 36.5-45.5 36.1-46.1
MH 40.7 ± 12.1 36.3 ± 10.3 ns 39.8 ± 12.4 38.6 ± 10.7 ns
CI 95% 37.2-44.3 31.9-40.8 35.9-43.8 34.5-42.6
SF-36v2 46.1 ± 10.5 42.3 ± 12.0 ns 45.8 ± 10.5 43.4 ± 11.9 ns
PCS CI 95% 43.0-49.1 37.1-47.5 42.6-49.2 38.9-47.9






















Table 3 Functional assessment in the physical and psychological domains in relation to impaired versus unimpaired CV of the median nerve for both hands
(Continued)
MCS CI 95% 38.7-45.6 32.3-43.1 37.4-45.1 35.4-44.4
QLI
HFSUB 20.4 ± 4.8 17.7 ± 5.3 0.05 19.9 ± 4.7 18.9 ± 5.6 ns
CI 95% 18.9-21.7 15.4-20.0 18.4-21.4 16.8-21.0
SOCSUB 21.7 ± 4.1 20.1 ± 3.6 ns 21.6 ± 3.9 20.7 ± 4.1 ns
CI 95% 20.6-22.9 18.5-21.6 20.7-22.8 19.2-22.3
PSPSUB 22.9 ± 5.0 21.0 ± 4.0 0.05 22.9 ± 4.8 21.4 ± 4.6 ns
CI 95% 21.5-24.4 19.3-22.7 21.4-24.5 19.7-23.1
FAMSUB 24.8 ± 4.3 24.2 ± 4.3 ns 25.5 ± 4.0 23.4 ± 4.4 0.03
CI 95% 23.6-26.1 22.3-26.1 24.2-26.7 21.8-25.1
QLI (Total) 21.7 ± 4.1 19.7 ± 4.1 0.05 21.6 ± 3.9 20.4 ± 4.3 ns
CI 95% 20.6-23.0 18.0-21.5 20.4-22.9 18.8-22.0
Data are presented as means ± SD and CI-confidence interval; the Mann–Whitney U-test was used for group comparisons (impaired vs. unimpaired). P values are expressed if they are <0.05. (AIS) Acceptance of Illness
Scale, (HADS) Hospital Anxiety and Depression Scale, (BI) Barthel Index, SF-36v2 = (PF) physical functioning, (SF) social functioning, (RP) physical role functioning, (RE) emotional role functioning, (BP) bodily pain, (GH)
general health, (VT) vitality, (MH) mental health, (PCS) physical component summary, (MSC) mental component summary, QLI-Quality of Life Index for Diabetes Version III = HFSUB- health and functioning subscale,
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subscale (PSPSUB; p = 0.05) and overall quality of life (QLI-
total; p = 0.05). As regards DML, differences between
groups were found for the left hand only in relation to the
social and economic subscale of the QLI (SOCSUB; p =
0.01). No differences between impaired and unimpaired
groups with respect to DML and CV were found for the
right hand on any of the functional assessment variables;
only deficits in nerve conductance as assessed with CV
appeared to distinguish between groups in relation to the
family subscale for QLI (FAMSUB; p = 0.03).
For the remaining analyses only CV are reported as
these appeared to be the more sensitive of the electro-
physiological measures of hand function used. Spearman
rank correlations (r) were calculated for both left and
right hand CV in relation to the parameters of interest
measured in this study (see Table 4). CV for the left
hand showed a strong negative correlation with HbA1c
(r = −0.36; p = 0.004) and positive correlations with the
BI (r = 0.31; p = 0.009) and the disease-specific measure
of quality of life (QLI) (r = 0.24; p = 0.04).
On multiple regression analysis, the generic measure of
quality of life (SF36) was significantly associated with de-
pression (HADS-D), patient age, acceptance of illness
(AIS), functional ability (BI) and conduction velocity for
the right hand (CV-R) and these predictor variables
accounted for 72.6% of the variance. In the model with
disease-specific quality of life (QLI) as the dependent vari-
able, there was a significant association with depression
(HADS-D), the level of the c-fraction of glycosylated
haemoglobin (HbA1c) and acceptance of illness (AIS),
these predictor variables accounting for 63.1% of the
variance.Table 4 Spearman rank correlations (r) between left and
right hand CV in relation to the parameters of interest
measured
Conduction velocities (r):
Left hand Right hand
Age −0.08 −0.14
Gender 0.15 0.08
Hb A1C −0.36** −0.15




SF-36v2 PCS 0.16 0.24*




It is generally accepted that the complications of dia-
betes are associated with poor metabolic control and
duration of illness [32]. Hand abnormalities have been
shown to be associated with duration of diabetes but not
with metabolic control or other complications of the
condition [17]. In the present study, hand dysfunctions
as measured by electrophysiological recordings of distal
motor latencies (DML) for the median nerve were asso-
ciated with duration of illness only for the left hand, al-
though a non-significant trend in a similar direction was
observed also for the right hand and for both hands
using nerve conduction velocities (CV). This result is in
keeping with that of the previous study [17] and reflects
the increased likelihood of peripheral neuropathy with
longer duration, and therefore most probably, severity of
illness. However, contrary to the results previously
reported [17], there was also a tendency for longer distal
latencies in the left hand to be associated with poor gly-
cemic control, as reflected in the levels of HbA1c, and
this reached significance for both hands on the measure
of nerve conduction velocity (CV), used to determine
median nerve function. Thus the results offer support
for the view that hand function appears to be affected by
poorer metabolic control in diabetes.
The aim of the present study was to investigate the ef-
fects of hand function on the quality of life of patients
with diabetes. Hand impairments, as reflected in the elec-
trophysiological measures used, occurred with equal fre-
quencies in both hands. However, the results show that
significant differences between impaired and unimpaired
median nerve conductance groups occurred only for the
left hand. Impaired groups achieved lower scores on the
quality of life instruments, supporting the hypothesis that
hand dysfunctions negatively affect quality of life. Specific-
ally, the domains of quality of life (SF36v2) which distin-
guished between impaired and unimpaired groups were
physical functioning (PF; p = .05), physical role perform-
ance (RP; p = .03), bodily pain (BP; p = .03) and general
health (GH; p = .03) for the two electrophysiological mea-
sures used.
Earlier work concerning quality of life in patients with
diabetes did not focus on any potential relationships
with neurophysiological measurements [33-35], with the
exception of Padua et al., who demonstrated an associ-
ation between nerve conductance and quality of life in
type 1 diabetes. They concluded that deficits in periph-
eral nerve function influence health related quality of life
(SF-36v2) on the physical (PCS) but not the mental
(MCS) components [15]. Our research provides add-
itional support for these findings in demonstrating that
deficits in median nerve conduction are associated with
lower quality of life in the physical but not mental com-
ponents of quality of life.
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QLI which is a disease-specific instrument for the meas-
urement of quality of life in diabetes. Deficits in con-
ductance of the left median nerve were found to reduce
quality of life in relation to the SOCSUB- social and eco-
nomic subscale, the HFSUB- health and functioning
subscale and the PSPSUB- psychological and spiritual
subscale, whilst conductance deficits in the right hand
reduced quality of life in relation to the FAMSUB- fam-
ily subscale. These data suggest that the QLI may be a
useful instrument in the assessment of dimensions of
quality of life, other than purely physical ones, in pa-
tients with diabetes and those with diabetic neuropathy.
They provide preliminary support for the suggestion that
the complications of diabetes may have broader implica-
tions for patients’ QOL than simply in the physical do-
main. Further studies are required to verify these results
and to clarify which of the possible social, health, psy-
chological and family aspects of functioning, if indeed
any, are reliably affected. Future work should also focus
on examining the relationships among key variables in
order to determine the mechanisms behind the alleged
effects on measures of outcome, such as QOL.
Differences were also found between impaired and un-
impaired groups in relation to ADL as measured by the
Barthel Index (BI) for both of the electrophysiological
measures used. One previous study, [2] reporting that
longer duration of diabetes was associated with an in-
creased likelihood of diabetic neuropathy and difficulties
in ADLs, also found that life satisfaction was high, and
contrary to the findings of the present study, hand dys-
function did not have a significant association with the
performance of ADLs. The reasons for this are not clear,
but it may be that floor effects obscured the existence of
any putative relationships i.e. high satisfaction with life
may have been a reflection of few difficulties with ADLs.
Depression frequently coexists with chronic illnesses
such as diabetes and significantly reduces the general
health status and quality of life of the population exam-
ined [36,37]. Depression is associated with hypergly-
cemia in diabetes, which in turn, increases the risk of
diabetic complications such as retinopathy, neuropathy
and nephropathy [38,39]. There have been conflicting re-
ports on the association between diabetic neuropathy
and depression, but on balance, the evidence appears to
support the existence of a relationship of this kind
[40,41]. In our study, there were no differences between
impaired and unimpaired groups on hand function in re-
lation to the occurrence of anxiety or depression as mea-
sured by the HADS, possibly indicating that upper limb
neuropathies are less likely to increase the occurrence of
depression in diabetic patients or that the HADS is an
insensitive measure of the psychopathology of diabetes.
This latter conclusion may be unfounded however, asLloyd et al., who consider the HADS to be an appropri-
ate instrument for the clinical study of depression in
adult patients with diabetes, have demonstrated a strong
association between glycemic control and psychological
symptoms, which was stronger for men than for women.
They found a significant relationship between patient
gender and glycaemic control (HbA1c) and with the oc-
currence of anxiety and depression [42]. These relation-
ships require further clarification.
One of the consequences of lack of illness acceptance
on the part of patients with diabetes is a failure to come
to terms with the restrictions imposed by the illness, a
lack of self-sufficiency, feelings of dependency on others
and reduced self-efficacy[43,44]. Patients with diabetic
neuropathy have greater difficulties in accepting their ill-
ness than patients with uncomplicated diabetes [43].
Our study however, did not reveal any significant differ-
ences between impaired and unimpaired groups in rela-
tion to electrophysiological recordings of hand function
and levels of illness acceptance.
The main findings of this study indicate that hand
function contributes to quality of life (SF36v2) in dia-
betes, although other factors, such as depression, patient
age, acceptance of illness and functional performance
are probably stronger determinants. The effect of hand
dysfunction is relatively weak as the addition of this vari-
able to the regression equation improves its ability to ac-
count for the variance by only a further 2%. With the
measure of QLI, depression and acceptance of illness re-
main strong determinants of quality of life, but glycemic
control (HbA1c) becomes an additional factor, although
age and ADL are not. This supports the contention that
the two measures of quality of life are likely to be tap-
ping somewhat different domains of life satisfaction.
Nevertheless mood and illness acceptance emerge as
making the most significant contribution to quality of
life. Further work needs to be done in order to under-
stand the relationships between the variables associated
with quality of life; for example, depression may be re-
lated to chronicity (and therefore age) in diabetes and
may in turn, affect ADL performance and acceptance of
illness, but other variations of these interrelationships
among variables are possible.
A possible limitation of this study is that, in focusing
on hand function, it does not provide a direct compari-
son with various control groups in order to test other
determinants of quality of life in diabetes. One such
comparison might involve patients with diabetes in
whom peripheral neuropathies have been established for
the lower limbs, and which might allow the differential
effects of functional impairment in upper and lower
limbs for QOL to be tested. However, no study is able to
take account of all possibilities and future studies are
needed to make the necessary comparisons. A complicating
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upper limbs, clinical symptoms are relatively rare, and
when they do occur, the diabetic neuropathy is already well
advanced in the legs and feet [45]. This means that dysfunc-
tions of the lower limbs which impair mobility and are as-
sociated with diabetic morbidity may be more significant
than hand function in terms of affecting quality of life, but
it may be difficult to tease apart their differential effects.
Nonetheless, this study, in having a specific focus, indicates
that the effects of hand function, albeit small, make a sig-
nificant contribution to quality of life.
As in all research attempting to disentangle the contri-
bution of a variety of complex factors to clinical condi-
tions, it may be the case that other factors that have not
been accounted for in this study, also exert an influence
on QOL in diabetes. One such factor may be the socio-
economic status (SES) of people with diabetes; for ex-
ample, Saydah & Lochner [46] have shown that in
patients with lower SES, the risk of mortality is doubled
compared to those of higher SES. It is plausible that SES
may be associated with important aspects of illness man-
agement, such as conformity to dietary restrictions and
medication regimens, those with poorer education levels
and lower economic status having greater difficulty in
adhering to advice in relation to the control of diabetes.
Systematic and reliable assessment of quality of life in
patients with diabetes provides valuable information
concerning those areas of functioning in which it is ne-
cessary to introduce significant changes. It is also of as-
sistance in determining new methods of treatment and
patient education [47]. The prevention of disability in
patients with recognized diabetic neuropathy may be
aided by rehabilitation procedures especially designed to
improve hand function.Conclusions
This study has demonstrated a small, but significant ef-
fect of hand function on quality of life. The effect was
found for the right hand on measures of CV, and may
reflect the greater sensitivity of this measure and the fact
that in people with right handed dominance (all of the
sample studied), integrity of the right hand is especially
important for both functional performance and quality
of life. Indeed, patients in whom nerve conductance
studies demonstrated impairment of the median nerve
in the left hand were found to have difficulties with the
activities of daily living as measured with the aid of the
Barthel Index and a diminished quality of life in the area
of physical functioning. Whilst no dependencies of this
kind were found for the right hand, this may be because
the neuropathic effects in the upper limbs are relatively
small and function in the right hand has greater com-
pensatory capacity than in the left.The study has also demonstrated that depression and
acceptance of illness are important contributors to quality
of life and their interrelationship with other variables re-
quires further study. Low mood and illness acceptance
may be the consequences of diabetic comorbidity reflected
in poor glycemic control and difficulty with ADLs or they
may arise independently of these complications, affecting
functional performance and quality of life.
As a result of the loss of functional ability in the
hands, patients with diabetes may experience greater dif-
ficulties in manipulating objects and this may lead to an
increased risk of accidents, for example, scalds and
burns incurred as the result of ADLs. Another area of
difficulty may be self-care activities, in particular those
connected with the measurement of glycemic status and
insulin injections. These findings may provide a basis for
drawing greater attention to hand function in diabetes,
both in terms of a better understanding of their contri-
bution to functional capacity, but also to their potential
effects on quality of life.
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